Stephen L Sabba - Net Worth and Insider Trading
Stephen L Sabba Net Worth
The estimated net worth of Stephen L Sabba is at least $2 Million dollars as of 2024-04-27. Stephen L Sabba is the Director of Ligand Pharmaceuticals Inc and owns about 28,926 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $2 Million. Details can be seen in Stephen L Sabba's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen L Sabba has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).
Transaction Summary of Stephen L Sabba
Stephen L Sabba Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen L Sabba owns 2 companies in total, including Ligand Pharmaceuticals Inc (LGND) , and Novelion Therapeutics Inc (NVLNF) .
Click here to see the complete history of Stephen L Sabba’s form 4 insider trades.
Insider Ownership Summary of Stephen L Sabba
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-03-05 | director |
| NVLNF | Novelion Therapeutics Inc | 2018-08-09 | director |
Stephen L Sabba Latest Holdings Summary
Stephen L Sabba currently owns a total of 1 stock. Stephen L Sabba owns 28,926 shares of Ligand Pharmaceuticals Inc (LGND) as of March 5, 2024, with a value of $2 Million.
Latest Holdings of Stephen L Sabba
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2024-03-05 | 28,926 | 70.57 | 2,041,308 |
Holding Weightings of Stephen L Sabba
Stephen L Sabba Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen L Sabba has made a total of 4 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 1,893 shares on March 5, 2024, which brought Stephen L Sabba around $140,650.
Insider Trading History of Stephen L Sabba
- 1
Stephen L Sabba Trading Performance
GuruFocus tracks the stock performance after each of Stephen L Sabba's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen L Sabba is 31.7%. GuruFocus also compares Stephen L Sabba's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen L Sabba within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen L Sabba's insider trading performs compared to the benchmark.
Performance of Stephen L Sabba
Average Return
80.97%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.72 | 31.7 | 47.95 | 80.97 | 78.88 | 60.5 |
| Relative Return to S&P 500(%) | 11.62 | 24.73 | 40.26 | 74.59 | 66.25 | 46.83 |
Stephen L Sabba Ownership Network
Ownership Network List of Stephen L Sabba
Ownership Network Relation of Stephen L Sabba
Stephen L Sabba Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Stephen L Sabba is the director of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , CHIEF LEGAL OFFICER & Andrew Reardon , and CEO & President John L Higgins .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Stephen L Sabba made 2 insider transaction in Ligand Pharmaceuticals Inc (LGND) with a net sale of 8,301. Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 20,000 shares made by John L Higgins , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 1,836 shares made by Octavio Espinoza .
In summary, during the past 3 months, insiders sold 2,033 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 2,033 shares. During the past 18 months, 41,289 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 37,289 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Stephen L Sabba Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen L Sabba. You might contact Stephen L Sabba via mailing address: Dorset Management Corp, 485 Underhill Blvd Suite 205, Syosset Ny 11791.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
